Implementation of a post-exposure tularemia treatment model for pneumonic challenged Fischer rats
Abstract
Francisella tularensis is the etiological agent of the potentially fatal disease tularemia. F. tularensis is sensitive to several antibiotic classes; however, the ability to derive antibiotic resistant Francisella strains has been well documented. Therefore, there is a need for new antimicrobials to be developed which requires animal models suitable to recapitulate critical inpatient therapy. We performed a proof-of-concept study utilizing intravenous catheterized rats which had been challenged with the Schu S4 strain of F. tularensis. Using gentamicin and levofloxacin as representative antibiotics, we first determined the pharmacokinetics from intravenous infusions of these drugs in rats to establish human-equivalent doses. Next, catheterized Fischer rats were aerosol challenged with F. tularensis. Three days after challenge, the rats received gentamicin or levofloxacin via intravenous infusion. Antibiotic or saline (vehicle control) was delivered twice daily for 14 days. All challenged rats provided antibiotic treatment survived to the end of the study. In contrast, the rats provided only saline succumbed or were euthanized in accordance with early endpoint euthanasia criteria by day 7 post-challenge. This study was purposely performed in two iterations to allow technical optimization. In the first iteration, catheter patency pre- and post-exposure was difficult to maintain leading to adverse clotting events and the loss of six rats. In the second iteration, animals were…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.